About ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a company based in Osaka (Japan) founded in 1947.. ONO PHARMACEUTICAL has completed 1 acquisition, including Deciphera. ONO PHARMACEUTICAL operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Osaka, Japan
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ono Pharmaceutical Co., Ltd.
-
Annual Revenue
$3.26 B (USD)-3.14as on Mar 31, 2025
-
Net Profit
$334.93 M (USD)-60.89as on Mar 31, 2025
-
EBITDA
$604.15 M (USD)-50.32as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ONO PHARMACEUTICAL
ONO PHARMACEUTICAL is a publicly listed company on the TSE with ticker symbol 4528 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of ONO PHARMACEUTICAL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ONO PHARMACEUTICAL
ONO PHARMACEUTICAL has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deciphera. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Type 2 kinase inhibitors for cancer treatment are developed.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ONO PHARMACEUTICAL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ono Pharmaceutical Comparisons
Competitors of ONO PHARMACEUTICAL
ONO PHARMACEUTICAL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ono Pharmaceutical
Frequently Asked Questions about ONO PHARMACEUTICAL
When was ONO PHARMACEUTICAL founded?
ONO PHARMACEUTICAL was founded in 1947.
Where is ONO PHARMACEUTICAL located?
ONO PHARMACEUTICAL is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
What is the annual revenue of ONO PHARMACEUTICAL?
Annual revenue of ONO PHARMACEUTICAL is $3.26B as on Mar 31, 2025.
What does ONO PHARMACEUTICAL do?
ONO Pharmaceutical was established in 1947 in Osaka, Japan, as a research and development entity within the pharmaceutical sector. Operations center on the production of medications targeting various therapeutic areas, including immunology and oncology. Services encompass drug discovery, clinical trials, and global distribution, with headquarters maintained in Japan and international partnerships facilitated.
Who are the top competitors of ONO PHARMACEUTICAL?
ONO PHARMACEUTICAL's top competitors include Merck, Roivant Sciences and AbbVie.
Is ONO PHARMACEUTICAL publicly traded?
Yes, ONO PHARMACEUTICAL is publicly traded on TSE under the ticker symbol 4528.
How many acquisitions has ONO PHARMACEUTICAL made?
ONO PHARMACEUTICAL has made 1 acquisition, including Deciphera.
What is ONO PHARMACEUTICAL's ticker symbol?
The ticker symbol of ONO PHARMACEUTICAL is 4528 on TSE.